Strenzik subcutaneous injection 12mg/0.3mL, containing Asfotase alpha (genetically recombined), is manufactured by Alexion Pharma. This injectable drug, with YJ code 3959418A1021 and standard 12mg x 0.3mL x 1 bottle, is an enzyme replacement therapy for perinatal/infantile- and juvenile-onset hypophosphatasia (HPP).
Strenzik subcutaneous injection 12mg/0.3mL
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →